基于氨酸的系统用于向大脑输送药物:桥梁材料设计和细胞反应
Carla Serri1, Mattia Danilo Langellotto2, Sanam Gull Arshad3
1Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy.
Expert opinion on drug delivery
|March 5, 2026
概括
氨酸 (HA) 聚合物显示为先进的大脑药物输送系统的前景. 这些粘膜粘合材料为治疗中枢神经系统 (CNS) 疾病提供可调节,生物相容的平台.
科学领域:
- 生物材料科学 生物材料科学
- 神经科学是一个神经科学.
- 药物输送系统 药物输送系统
背景情况:
- 粘膜聚合物对于先进的脑疗法越来越重要.
- 氨酸 (HA) 是一种高度调节的,生物相容的聚合物,适用于通过各种途径治疗中枢神经系统 (CNS) 疾病.
研究的目的:
- 批判性地检查基于HA的脑药物输送平台的近期进展.
- 专注于用于HA合成,功能化和处理的新策略.
- 探索先进的载体设计与分子向的集成,以提高中枢神经系统药物输送.
主要方法:
- 对HA合成和功能化中新兴策略的审查.
- 对用于药物输送应用的HA加工技术的分析.
- 集成先进的载体设计与分子准原则.
主要成果:
- 基于HA的平台可以提高药物向性和在中枢神经系统内的精确治疗调制.
- 这些系统可以改善大脑积累和安全概况.
- HA平台促进了神经系统疾病的多式联络治疗策略.
结论:
- 基于HA的平台为改善药物向,治疗疗效和中枢神经系统疾病患者的治疗结果提供了显著的潜力.
- 克服制造,可扩展性和翻译方面的挑战对于临床实现至关重要.
相关概念视频
Modified-Release Drug Delivery Systems: Stimuli-Activated
58
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
58
Modified-Release Drug Delivery Systems: Rate-Programmed II
58
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
58
The Blood-brain Barrier
54.2K
Overview
54.2K
Site-Targeted Drug Delivery Systems: Polymeric Carriers
64
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
64
Drug Delivery: Parenteral Route
2.0K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
2.0K
Modified-Release Drug Delivery Systems: Site-Targeted
57
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
57


